BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15100460)

  • 1. Ethnic differences in polymorphisms of tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 genes in patients with chronic hepatitis C virus infection.
    Zein NN; Germer JJ; El-Zayadi AR; Vidigal PG
    Am J Trop Med Hyg; 2004 Apr; 70(4):434-7. PubMed ID: 15100460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.
    Ben-Ari Z; Pappo O; Druzd T; Sulkes J; Klein T; Samra Z; Gadba R; Tambur AR; Tur-Kaspa R; Mor E
    Cytokine; 2004 Jul; 27(1):7-14. PubMed ID: 15207246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms.
    Cheong JY; Cho SW; Hwang IL; Yoon SK; Lee JH; Park CS; Lee JE; Hahm KB; Kim JH
    J Gastroenterol Hepatol; 2006 Jul; 21(7):1163-9. PubMed ID: 16824070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of tumor necrosis factor-alpha, transforming growth factor-beta 1, interleukin-10, and interferon-gamma polymorphisms in patients with alcoholic chronic pancreatitis.
    Schneider A; Barmada MM; Slivka A; Martin JA; Whitcomb DC
    Alcohol; 2004 Jan; 32(1):19-24. PubMed ID: 15066699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection--association between TGF-beta1 polymorphisms and hepatocellular carcinoma.
    Migita K; Miyazoe S; Maeda Y; Daikoku M; Abiru S; Ueki T; Yano K; Nagaoka S; Matsumoto T; Nakao K; Hamasaki K; Yatsuhashi H; Ishibashi H; Eguchi K
    J Hepatol; 2005 Apr; 42(4):505-10. PubMed ID: 15763337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in tumour necrosis factor-alpha, transforming growth factor-beta, interleukin-10, interleukin-6, interferon-gamma, and outcome of hepatitis C virus infection.
    Barrett S; Collins M; Kenny C; Ryan E; Keane CO; Crowe J
    J Med Virol; 2003 Oct; 71(2):212-8. PubMed ID: 12938195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of TNF-beta polymorphism with disease severity among patients infected with hepatitis C virus.
    Goyal A; Kazim SN; Sakhuja P; Malhotra V; Arora N; Sarin SK
    J Med Virol; 2004 Jan; 72(1):60-5. PubMed ID: 14635012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical importance of transforming growth factor-beta but not of tumor necrosis factor-alpha gene polymorphisms in patients with the myelodysplastic syndrome belonging to the refractory anemia subtype.
    Balog A; Borbényi Z; Gyulai Z; Molnár L; Mándi Y
    Pathobiology; 2005; 72(3):165-70. PubMed ID: 15860935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of tumour necrosis factor alpha promoter polymorphisms at position -308 and -238 with clinical characteristics of chronic hepatitis C.
    Dai CY; Chuang WL; Lee LP; Chen SC; Hou NJ; Lin ZY; Hsieh MY; Hsieh MY; Wang LY; Chang WY; Yu ML
    J Viral Hepat; 2006 Nov; 13(11):770-4. PubMed ID: 17052277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host genetic factors influence disease progression in chronic hepatitis C.
    Powell EE; Edwards-Smith CJ; Hay JL; Clouston AD; Crawford DH; Shorthouse C; Purdie DM; Jonsson JR
    Hepatology; 2000 Apr; 31(4):828-33. PubMed ID: 10733535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus.
    Miyazoe S; Hamasaki K; Nakata K; Kajiya Y; Kitajima K; Nakao K; Daikoku M; Yatsuhashi H; Koga M; Yano M; Eguchi K
    Am J Gastroenterol; 2002 Aug; 97(8):2086-92. PubMed ID: 12190181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor-alpha, transforming growth factor-β1, and interleukin-10 gene polymorphisms: implication in protection or susceptibility to dengue hemorrhagic fever.
    Perez AB; Sierra B; Garcia G; Aguirre E; Babel N; Alvarez M; Sanchez L; Valdes L; Volk HD; Guzman MG
    Hum Immunol; 2010 Nov; 71(11):1135-40. PubMed ID: 20732366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between transforming growth factor-beta 1 polymorphism and virologic characteristics of chronic hepatitis C.
    Dai CY; Chuang WL; Lee LP; Pan WC; Huang JF; Hsieh MY; Hou NJ; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Yu ML
    Transl Res; 2008 Oct; 152(4):151-6. PubMed ID: 18940717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of transforming growth factor-beta1, interleukin-8, and tumor necrosis factor-alpha polymorphisms in patients with chronic pancreatitis.
    Farkas G; Hofner P; Balog A; Takács T; Szabolcs A; Farkas G; Mándi Y
    Eur Cytokine Netw; 2007 Mar; 18(1):31-7. PubMed ID: 17400536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms within the tumor necrosis factor-alpha promoter region in patients with HLA-B27-associated uveitis: association with susceptibility and clinical manifestations.
    El-Shabrawi Y; Wegscheider BJ; Weger M; Renner W; Posch U; Ulrich S; Ardjomand N; Hermann J
    Ophthalmology; 2006 Apr; 113(4):695-700. PubMed ID: 16581430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor-α promoter gene polymorphisms are not associated with hepatitis C virus infection in Chinese hemodialysis patients.
    Zhang X; Hu D; Zhu B; Wang C; He J; Wu J; Yu RB; Zhao WH
    Ren Fail; 2011; 33(6):593-9. PubMed ID: 21631181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of transforming growth factor-β1 and tumor necrosis factor-α genes polymorphisms on the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis C patients.
    Radwan MI; Pasha HF; Mohamed RH; Hussien HI; El-Khshab MN
    Cytokine; 2012 Oct; 60(1):271-6. PubMed ID: 22682513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine polymorphisms in patients with pemphigus.
    Eberhard Y; Burgos E; Gagliardi J; Vullo CM; Borosky A; Pesoa S; Serra HM
    Arch Dermatol Res; 2005 Jan; 296(7):309-13. PubMed ID: 15650893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms in patients with myelodysplastic syndrome.
    Gyulai Z; Balog A; Borbényi Z; Mándi Y
    Acta Microbiol Immunol Hung; 2005; 52(3-4):463-75. PubMed ID: 16400883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The -670A > G polymorphism in the promoter region of the FAS gene is associated with necrosis in periportal areas in patients with chronic hepatitis C.
    Aguilar-Reina J; Ruiz-Ferrer M; Pizarro MA; Antiñolo G
    J Viral Hepat; 2005 Nov; 12(6):568-73. PubMed ID: 16255757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.